C07D 279/28
With other substituents attached to the ring system
Official title: with other substituents attached to the ring system
C07D279/28 (With other substituents attached to the ring system) appears on 65 US grants and 73 published applications in this corpus.
Search patents in C07D- Granted patents
- 65
- Published applications
- 73
- Assignees
- 86
- Inventors
- 226
- Latest grant
- 15 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 4 |
| 2005 | 0 | 2 |
| 2006 | 3 | 3 |
| 2007 | 2 | 3 |
| 2008 | 2 | 3 |
| 2009 | 3 | 3 |
| 2010 | 1 | 13 |
| 2011 | 5 | 4 |
| 2012 | 2 | 5 |
| 2013 | 3 | 2 |
| 2014 | 0 | 3 |
| 2015 | 3 | 4 |
| 2016 | 2 | 1 |
| 2017 | 5 | 2 |
| 2018 | 3 | 2 |
| 2019 | 2 | 4 |
| 2020 | 2 | 2 |
| 2021 | 3 | 2 |
| 2022 | 0 | 2 |
| 2023 | 2 | 1 |
| 2024 | 1 | 3 |
| 2025 | 1 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compound, hole transport material, and photoelectric conversion element including same15 Apr 2025US 12,279,523 B2Hodogaya Chemical Co., Ltd.
- Phenothiazine derivatives and uses thereof19 Nov 2024US 12,145,963 B2Camp4 Therapeutics Corporation
- Ubiquitin-specific peptidase 24 inhibitor, medicinal composition including the same and method of delaying or reversing multidrug resistance in cancers using the same28 Nov 2023US 11,827,611 B2National Cheng Kung University
- Phenothiazine derivatives and uses thereof3 Jan 2023US 11,542,290 B2Camp4 Therapeutics Corporation
- Anti-infective heterocyclic compounds and uses thereof28 Sep 2021US 11,130,741 B2Bioimics AB
- Dynamin activators12 Mar 2026US 2026/0070880 A1Walden Biosciences, Inc.
- Tpk agonist and method for treating neurodegenerative diseases using same25 Dec 2025US 2025/0388584 A1Shanghai Raising Pharmaceutical Co., Ltd.
- Drug combinations for inhibiting coronavirus replication20 Feb 2025US 2025/0057819 A1
- Phenothiazine derivatives and uses thereof30 Jan 2025US 2025/0034193 A1Camp4 Therapeutics Corporation
- Compound, hole transport material, and photoelectric conversion element including same21 Mar 2024US 2024/0099128 A1Hodogaya Chemical Co., Ltd.
Most cited
By later US patents
- Agmatine, and polyaminoguanidine-bound heterocyclic compounds for neurotrauma and neurodegenerative diseases27US 6,114,392 A2000
- Agmatine for the treatment of neurotrauma and neurodegenerative diseases23US 5,677,349 A1997
- Branched chain phenothiazine20US 4,634,699 ABurroughs Wellcome Co. · 1987
- Methylene blue—curcumin analog for the treatment of alzheimer's disease19US 7,723,515 B1Codman & Shurtleff, Inc. · 2010
- Electrochemical energy storage devices14US 9,964,828 B2Gentex Corporation · 2018